Evidence map›Paper›PMID 39534047›Full record

ArticleRSC advances2024

Physicochemical properties and mechanism of action of a new copper(ii) pyrazine-based complex with high anticancer activity and selectivity towards cancer cells.

B Rogalewicz, T Sierański, M Szczesio, A Olczak, K Gobis, C Orlewska, I Korona-Głowniak, A Korga-Plewko, M Iwan, M Michalczuk and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

B RogalewiczInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.ORCID https://orcid.org/0000-0002-9899-6402
T SierańskiInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.ORCID https://orcid.org/0000-0002-4736-5280
M SzczesioInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.
A OlczakInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.
K GobisDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdansk Gen. Hallera 107 Gdańsk 80-416 Poland.
C OrlewskaDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdansk Gen. Hallera 107 Gdańsk 80-416 Poland.
I Korona-GłowniakDepartment of Pharmaceutical Microbiology, Medical University of Lublin Lublin 20-093 Poland.
A Korga-PlewkoIndependent Medical Biology Unit, Medical University of Lublin Jaczewskiego 8b Lublin 20-093 Poland.
M IwanDepartment of Toxicology, Medical University of Lublin Chodźki 8b Lublin 20-093 Poland.
M MichalczukIndependent Medical Biology Unit, Medical University of Lublin Jaczewskiego 8b Lublin 20-093 Poland.
J KubikIndependent Medical Biology Unit, Medical University of Lublin Jaczewskiego 8b Lublin 20-093 Poland.
G AdamczukIndependent Medical Biology Unit, Medical University of Lublin Jaczewskiego 8b Lublin 20-093 Poland.
M KorgaIndependent Medical Biology Unit, Medical University of Lublin Jaczewskiego 8b Lublin 20-093 Poland.
N RutkowskaInstitute of Molecular and Industrial Biotechnology, Lodz University of Technology Stefanowskiego 2/22 Lodz 90-537 Poland.ORCID https://orcid.org/0000-0002-0902-9489
T BorutaFaculty of Process and Environmental Engineering, Department of Bioprocess Engineering, Lodz University of Technology ul. Wolczanska 213 Lodz 93-005 Poland.
K GasInstitute of Physics, Polish Academy of Sciences Aleja Lotnikow 32/46 Warsaw PL-02668 Poland.ORCID https://orcid.org/0000-0003-3722-764X
M SawickiInstitute of Physics, Polish Academy of Sciences Aleja Lotnikow 32/46 Warsaw PL-02668 Poland.ORCID https://orcid.org/0000-0001-5740-3677
E PoleszakLaboratory of Preclinical Testing, Chair and Department of Applied and Social Pharmacy, Medical University of Lublin Chodzki 1 Lublin 20-093 Poland.
W ManiukiewiczInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.ORCID https://orcid.org/0000-0001-6094-0748
M ŚwiątkowskiInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.ORCID https://orcid.org/0000-0003-4362-0499
A CzylkowskaInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology Żeromskiego 116 Lodz 90-924 Poland bartlomiej.rogalewicz@dokt.p.lodz.pl agnieszka.czylkowska@p.lodz.pl.ORCID https://orcid.org/0000-0001-7157-5408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two compounds, benzyl-2-(amino(pyrazin-2-yl)methylene)-1-methylhydrazine-1-carbodithioate (L) and its copper(ii) complex Cu(L) were synthesized and studied in terms of their physicochemical properties, including single crystal, spectroscopic and magnetic properties;

Identifiers

PMID39534047
PMCPMC11556459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.